Show items per page
Elements: 162
Page 1 on 4
 TitleAuthors / EditorsDate
add to browser selection
Zweitinfektion mit HIV: Mythos oder Realitat? Vernazza, P. L.; Bernasconi, Enos; Hirschel, Bernard 2000
add to browser selection
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV Young, Jim; Bucher, H. C.; Guenthard, H. F.; Rickenbach, Martin; ... Battegay, Manuel 2009
add to browser selection
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F 2011
add to browser selection
Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study Weber, R.; Huber, M.; Rickenbach, M.; Furrer, Hansjakob; ... Ledergerber, Bruno 2009
add to browser selection
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study Rauch, Andri; Rickenbach, Martin; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2005
add to browser selection
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes Fenner, Lukas; Gagneux, Sebastien; Janssens, Jean-Paul; Fehr, Jan; ... Egger, Matthias 2012
add to browser selection
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study Beguelin, Charles; Suter, Annatina; Bernasconi, Enos; Fehr, Jan; ... Calmy, Alexandra 2018
add to browser selection
Treatment-Naive Individuals Are the Major Source of Transmitted HIV-1 Drug Resistance in Men Who Have Sex With Men in the Swiss HIV Cohort Study Drescher, Sara M; von Wyl, Viktor; Yang, Wan-Lin; Böni, Jürg; ... Calmy, Alexandra 2014
add to browser selection
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study Gonvers, Jean-Jacques; Heim, Markus H.; Cavassini, Matthias; Mullhaupt, Beat; ... Oneta, Carl 2010
add to browser selection
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008 Elzi, Luigia; Marzolini, Catia; Furrer, Hansjakob; Ledergerber, Bruno; ... Battegay, Manuel 2010
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in Switzerland von Wyl, V.; Kouyos, R. D.; Yerly Ferrillo, Sabine; Boni, J.; ... Gunthard, H. F. 2011
add to browser selection
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control study Felley, Christian; Morris, Michael Andréw; Wonkam, Ambroise; Hirschel, Bernard; ... Frossard, Jean-Louis 2004
add to browser selection
The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study Wang, Qing; Young, Jim; Bernasconi, Enos; Cavassini, Matthias; ... Martinez De Tejada Weber, Begona 2013
add to browser selection
The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients Beerenwinkel, Niko; Montazeri, Hesam; Schuhmacher, Heike; Knupfer, Patrick; ... Calmy, Alexandra 2013
add to browser selection
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients Bibert, Stéphanie; Wojtowicz, Agnieszka; Taffe, Patrick; Manuel, Oriol; ... Bochud, Pierre-Yves 2014
add to browser selection
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study Fux, C. A.; Rauch, Andri; Simcock, Mathew; Bucher, H. C.; ... Furrer, Hansjakob 2008
add to browser selection
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study Fux, C. A.; Simcock, Mathew; Wolbers, Marcel; Bucher, H. C.; ... Furrer, Hansjakob 2007
add to browser selection
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort Hirschel, Bernard; Flepp, Markus; Bucher, H. C.; Zellweger, Claudine; ... Ledergerber, Bruno 2002
add to browser selection
Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008 Keiser, Olivia; Spoerri, Adrian; Brinkhof, Martin W. G.; Hasse, Barbara; ... Egger, Mathias 2010
add to browser selection
Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study Scherrer, Alexandra U; Yang, Wan-Lin; Kouyos, Roger D; Böni, Jürg; ... Günthard, Huldrych F 2016
add to browser selection
Study protocol for a multicentre, cluster randomised, superiority trial evaluating the impact of computerised decision support, audit and feedback on antibiotic use: the COMPuterized Antibiotic Stewardship Study (COMPASS) Catho, Gaud; De Kraker, Marlieke; Waldispühl Suter, Brigitte; Valotti, Roberta; ... Huttner, Benedikt 2018
add to browser selection
Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population Hasse, Barbara; Tarr, Philip E; Marques-Vidal, Pedro; Waeber, Gerard; ... Martinetti, Gregory 2015
add to browser selection
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study Young, Jim; De Geest, Sabina; Spirig, Rebecca; Flepp, Markus; ... Bucher, H. C. 2004
add to browser selection
Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients Glass, T. R.; De Geest, Sabina; Hirschel, Bernard; Battegay, Manuel; ... Bucher, H. C. 2008
add to browser selection
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study Conen, Anna; Fehr, Jan; Glass, T. R.; Furrer, Hansjakob; ... Battegay, Manuel 2009
add to browser selection
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial Csaki Huttner, Angela; Hatz, Christoph; van den Dobbelsteen, Germie; Abbanat, Darren; ... Fonck, Veronica Gambillara 2017
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS) Nüesch, Reto; Wang, Qing; Elzi, Luigia; Bernasconi, Enos; ... Bucher, Heiner C 2013
add to browser selection
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study Sculier, Delphine; Gayet-Ageron, Angèle; Battegay, Manuel; Cavassini, Matthias; ... Calmy, Alexandra 2017
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals: the Swiss HIV Cohort Study Fehr, Jan; Glass, Tracy R; Louvel, Séverine; Hamy, François; ... Klimkait, Thomas 2011
add to browser selection
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir Young, Jim; Schäfer, Juliane; Fux, Christoph A; Furrer, Hansjakob; ... Bucher, Heiner C 2012
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland Kusejko, K; Marzel, A; Hampel, B; Bachmann, N; ... Kouyos, R D 2018
add to browser selection
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study Wolf, Katja; Young, James; Rickenbach, Martin; Vernazza, Pietro; ... Bucher, H. C. 2003
add to browser selection
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study Glass, T. R.; Ungsedhapand, C.; Wolbers, M.; Weber, R.; ... Bucher, H. C. 2006
add to browser selection
Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study Marzolini, Catia; Elzi, Luigia; Gibbons, Sara; Weber, Rainer; ... Battegay, Manuel 2010
add to browser selection
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study Fellay, Jacques; Boubaker, K.; Ledergerber, Bruno; Bernasconi, Enos; ... Telenti, A. 2001
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period Aebi-Popp, K; Kouyos, R; Bertisch, Barbara; Staehelin, C; ... Fehr, J 2016
add to browser selection
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication Ciuffreda, Donatella; Comte, Denis; Cavassini, Matthias; Giostra, Emiliano; ... Dutoit, Valerie 2008
add to browser selection
Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load Alizon, Samuel; von Wyl, V.; Stadler, T.; Kouyos, R. D.; ... Bonhoeffer, S. 2010
add to browser selection
Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals Lubomirov, Rubin; Arab, Mona; Rotger, Margalida; Fayet-Mello, Aurélie; ... Telenti, Amalio 2013
add to browser selection
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study Thierfelder, C; Weber, R; Elzi, L; Furrer, H; ... Ledergerber, B 2012
add to browser selection
Overall burden of healthcare-associated infections among surgical patients. Results of a national study Sax, Hugo; Uckay, Ilker; Balmelli, Carlo; Bernasconi, Enos; ... Pittet, Didier 2011
add to browser selection
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study Osih, Regina B.; Taffe, Patrick; Rickenbach, Martin; Gayet-Ageron, Angèle; ... Cavassini, Matthias 2010
add to browser selection
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians Huber, M; Ledergerber, B; Sauter, R; Young, J; ... Weber, R 2012
add to browser selection
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection Metzner, Karin J; Scherrer, Alexandra U; Preiswerk, Benjamin; Joos, Beda; ... Günthard, Huldrych F 2013
<< previous | 1 | 2 | 3 | 4 |